For in vitro diagnostic use. Others BUP IVD BUP CPS_000053 Buprenorphine Enzyme Immunoassay 08 362 955 190 8 362 955 190 08362955190 8362955190 08362955190 BUP, 200T, cobas c, PCh BUP 00850624008018 Reagents, kits 200 tests cobas c 501/502 true 09 067 752 190 9 067 752 190 09067752190 9067752190 09067752190 BUP, 240T, cobas c pack green, PCh BUP 00850624008513 Reagents, kits 240 tests cobas c 303/503/703 true 0009067752190c503 BUP Buprenorphine Enzyme Immunoassay en 4 C10000000009EA0E FF00000004C9770E 09067752190 9493 cobas c 303 8481 cobas c 503 10299 cobas c 703 Product information shown on this page contains elements of the officially released Method Sheet. If you require further information please refer to the full Method Sheet PDF under the given link, or contact your local Roche country representative. Intended use The Lin-Zhi International, Inc. (LZI) Buprenorphine Enzyme Immunoassay is intended for the qualitative and semi‑quantitative determination of norbuprenorphine (a buprenorphine metabolite) in human urine at a cutoff value of 5 ng/mL and 10 ng/mL. The assay is designed for professional use with a number of automated clinical chemistry analyzers.The assay provides only a preliminary analytical result. A more specific alternative analytical chemistry method must be used in order to obtain a confirmed analytical result. Gas or Liquid Chromatography/Mass Spectrometry (GC/MS or LC/MS) are the preferred confirmatory methods.ReferencesReferences Clinical consideration and professional judgment should be exercised with any drug of abuse test result, particularly when the preliminary test result is positive. en

User profile

Select your user profile

BUP

test

Overview

Ordering information

Technical documents

Compatible products

Contact us